pillbase.ru

EGRIFTA WR

Active substance: tesamorelin

KIT · tesamorelin

United StatesActive

Marketing holder: Theratechnologies Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 1
  • Egrifta
    tesamorelin
    EMEA/H/C/002427
    Ferrer Internacional S.A.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208e-97a7-7088-a0fe-8aa7c719064d,01a1209b-77c9-79ab-b129-59e6b55f07e5;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
62064-381
Registration status
Active
Dispensing
Prescription only
Route
SUBCUTANEOUS
Sources
  • product · openFDA NDC · 62064-381 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 62064-381 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 62064-381 · Verified 2026-10-09 · open in source